Look beyond the format of a visit
Telehealth is care given through a phone, video connection or online exchange instead of sharing a room.
The Massachusetts board holds doctors to the same standard of care over a screen as in person, under its policy checked September 30, 2026.
That means the format has to fit the assessment. It does not mean every problem can be handled through a screen.
Check the rules for the actual medicine
Because some medicines can be misused, the government closely tracks them as controlled drugs. Testosterone is one; semaglutide and tirzepatide are not, under federal rules checked September 26, 2026.
For medicines outside that controlled group, a first visit in person is not required by federal rules checked September 26, 2026.
Controlled drugs normally have an in-person examination rule. As of September 26, 2026, a temporary exception allows remote prescribing when its conditions are met, through December 31, 2026.
Ask the clinician whether any in-person rule applies to your medicine and whether an exception covers your visit. Separately, ask whether your health concern needs an examination in a room.
Ask how the service handles the gaps
National medical-board guidance says that when an assessment needs tests or an in-person exam, the doctor needs to complete, arrange or refer for that care.
Boards can use this guidance; it does not have the force of national law.
- Would any part of my assessment need to happen in a room?
- Who arranges a test if the clinician thinks it is needed?
- If I am travelling during a follow-up, how will my location affect the visit?
- Can I ask the clinician questions before a decision is made?
Use those answers to compare a licensed telehealth service with a clinic you would visit in person. The goal is a clear route from assessment to follow-up.